Equities

NorthWest Healthcare Properties REIT

NorthWest Healthcare Properties REIT

Actions
Real EstateReal Estate Investment Trusts
  • Price (USD)3.47
  • Today's Change-0.06 / -1.70%
  • Shares traded9.91k
  • 1 Year change-44.03%
  • Beta--
Data delayed at least 15 minutes, as of Apr 17 2024 20:18 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Northwest Healthcare Properties Real Estate Investment Trust is a Canada-based open-ended real estate investment trust. The Company operates in the healthcare real estate industry segment. Its businesses include funds management, asset management, and development. It focuses on the cure segment of healthcare real estate, such as hospitals, medical office buildings, and clinics. Its asset class segmentation includes hospitals and healthcare facilities; medical office buildings, and life sciences, research, and education. It provides a portfolio of international healthcare real estate infrastructure comprised of interests in a diversified portfolio of approximately 231 income-producing properties and 18.5 million square feet of gross leasable area located throughout markets in Canada, the United States, Brazil, Europe, Australia, and New Zealand. Its portfolio of medical office buildings, clinics, and hospitals is characterized by long-term indexed leases and stable occupancies.

  • Revenue in CAD (TTM)508.00m
  • Net income in CAD-347.69m
  • Incorporated2010
  • Employees275.00
  • Location
    NorthWest Healthcare Properties REIT180 Dundas St W Suite 1100TORONTO M5G 1Z8CanadaCAN
  • Phone+1 (416) 366-2000
  • Fax+1 (416) 366-2433
  • Websitehttps://www.nwhreit.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.